Intuitive Staging Correlates With King's Clinical Stage
- PMID: 33821690
- PMCID: PMC7611335
- DOI: 10.1080/21678421.2020.1867181
Intuitive Staging Correlates With King's Clinical Stage
Abstract
Background: Clinical stage in amyotrophic lateral sclerosis (ALS) can be assigned using King's staging with a simple protocol based on the number of CNS regions involved and the presence of significant nutritional or respiratory failure. It is important that the assigned clinical stage matches expectations, and generally corresponds with how a health care professional would intuitively stage the patient. We therefore investigated the relationship between King's clinical ALS stage and ALS stage as intuitively assigned by health care professionals. Methods: We wrote 17 case vignettes describing people with ALS at different disease stages from very early limited disease involvement through to severe, multi-domain disease. During two workshops, we asked health care professionals to intuitively stage the vignettes and compared the answers with the actual King's clinical ALS stage. Results: There was a good correlation between King's clinical ALS stage and intuitively assigned stage, with a Spearman's Rank correlation coefficient of 0.64 (p < 0.001). There was no difference in the intuitive stages assigned by practitioners of different types or at different levels of experience. Conclusions: Across a spectrum of ALS scenarios, King's clinical ALS stage corresponds to intuitive ALS stage as assigned by a range of health care professionals.
Keywords: King’s stage; Prognosis; biomarker; clinical stage; prognostic; survival; ventilation.
Conflict of interest statement
AAC is a consultant for Mitsubishi-Tanabe Pharma, GSK, and Chronos Therapeutics, and chief investigator for clinical trials for Cytokinetics and OrionPharma.
Figures
References
-
- Al-Chalabi A, Hardiman O, Kiernan MC, Chiò A, Rix-Brooks B, van den Berg LH, et al. Amyotrophic lateral sclerosis: moving towards a new classification system. [cited 2016 Sep 21];Lancet Neurol. 2016 Oct;15(11):1182–94. [Internet], Available from: http://linkinghub.elsevier.com/retrieve/pii/S1474442216301995. - PubMed
-
- Pupillo E, Messina P, Logroscino G, Beghi E. Long-term survival in amyotrophic lateral sclerosis: A population-based study. Ann Neurol. 2014;75(2):287–97. - PubMed
-
- Knibb JA, Keren N, Kulka A, Leigh PN, Martin S, Shaw CE, et al. A clinical tool for predicting survival in ALS. J Neurol Neurosurg Psychiatry. 2016:1–7. [Internet], Available from: http://www.ncbi.nlm.nih.gov/pubmed/27378085. - PMC - PubMed
-
- Westeneng H-J, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018 - PubMed
Publication types
MeSH terms
Grants and funding
- MR/L501529/1/MRC_/Medical Research Council/United Kingdom
- ALCHALABI-TALBOT/APR14/926-794/MNDA_/Motor Neurone Disease Association/United Kingdom
- 107196/Z/14/Z/WT_/Wellcome Trust/United Kingdom
- MR/R024804/1/MRC_/Medical Research Council/United Kingdom
- RP-PG-1016-20006/DH_/Department of Health/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous